SB 438 prevents health insurance companies and health plans in Oklahoma from requiring providers (like doctors, hospitals, or clinics) to accept only credit card payments for services. It mandates that insurers must notify providers about any fees tied to payment methods and provide clear instructions for choosing alternatives like electronic transfers. The bill also prohibits charging fees for standard electronic payments (ACH) without provider consent and voids any contract clauses that try to bypass these rules. These changes directly affect health insurers, health plans, and healthcare providers across Oklahoma, taking effect November 1, 2025.
HB 1585 establishes mandatory training requirements for pharmacy technicians in Oklahoma. It requires pharmacy technicians to complete two phases of training: Phase I before receiving a permit, and Phase II within 90 days of permit issuance. Pharmacy managers must develop, document, and verify all training, with failure to complete Phase II voiding the permit. The law directly affects pharmacy technicians seeking permits, their employers (pharmacy managers), and the Oklahoma Pharmacy Board, which oversees compliance. The bill takes effect November 1, 2025.
HB 2087 modifies Oklahoma's income tax credit for donations to qualified research institutes. It adjusts annual funding caps: for biomedical research institutes, the limit drops from $2 million to $1.5 million per year starting in 2026, while cancer research institute credits are capped at $500,000 annually. The credit percentage for each donation type is recalculated yearly based on prior-year claims, using specific formulas to stay within these new limits. Taxpayers donating to qualifying nonprofit biomedical or cancer research institutes (defined by NIH funding requirements) can claim the credit, with individual limits of $1,000-$25,000 depending on filing status or business type.
HB 1380 creates Oklahoma's Insulin Access and Affordability Program within the State Department of Health to lower insulin costs and improve access. The program requires the state to partner with nonprofit pharmaceutical companies and organizations to secure fast-acting insulin at capped prices: $30 per vial or $55 per pack of five pre-filled pens, with agreements detailing projected savings for Oklahoma residents and self-insured plans. It directly affects Oklahomans using insulin, particularly those on public or private insurance, by aiming to reduce out-of-pocket costs through competitive pricing. The program takes effect July 1, 2025, and requires nonprofits to commit to specific price points and savings reporting.
HB 2754 establishes the Oklahoma Rural Hospitals Funding Assistance Grant Program to provide financial support to qualifying rural hospitals. It directly affects publicly owned hospitals in towns with fewer than 5,000 residents that meet federal critical access hospital standards. The program creates a revolving fund in the state treasury, administered by the State Department of Health, to award grants prioritizing areas with significant healthcare access barriers due to distance. Grants are limited to the total funds available in the revolving fund, and the program becomes effective July 1, 2025.
HB 2012 removes the July 1, 2026, expiration date for Oklahoma's harm-reduction services program, making it permanent. It authorizes government agencies, religious institutions, nonprofits, for-profit companies, and tribal governments to provide services including needle distribution, HIV/hepatitis testing, referrals for addiction treatment, and safe needle disposal. Providers must register with the State Department of Health and report quarterly on services delivered, such as the number of people served, needles distributed, and test results. This bill directly affects people who use injection drugs by expanding access to health services aimed at reducing disease transmission and overdose risks.
HB 1686 requires hospitals to establish evidence-based sepsis protocols for early identification and treatment of patients with sepsis or septic shock, including staff training and population-specific guidelines (e.g., for pediatric or adult patients). It also mandates that Medicaid payors and health insurance plans (including private insurers) use specific clinical criteria for sepsis billing: a provider’s diagnosis of sepsis plus two symptoms of inflammatory response (such as fever, rapid heartbeat, or abnormal white blood cell count). The bill directly affects hospitals providing care and insurance companies administering Medicaid or health benefit plans in Oklahoma. It becomes effective November 1, 2025, aligning with federal coding standards for sepsis diagnosis.
HB 2051 creates Oklahoma's "Supervised Physicians Act," establishing a temporary pathway for medical school graduates to practice under supervision. It directly affects Oklahoma medical school graduates who have passed required exams but lack full licensure, requiring them to enter a collaborative practice arrangement with a fully licensed Oklahoma supervising physician who meets specialty qualifications. Key provisions include a two-year temporary license (non-renewable), mandatory identification as a "supervised physician" via name tags/lab coats, and prohibitions against independent practice without the approved arrangement. The bill does not create a full licensure alternative but sets specific rules for this supervised practice period, with oversight by the State Board of Medical Licensure.
HB 1853 requires health insurance plans covering children to provide full, cost-sharing-free coverage for all recommended childhood immunizations (including those mandated by the State Board of Health) from birth through age 18. It also allows policyholders to pay for health care services directly at a negotiated lower rate and submit documentation to have that payment count toward their deductible. The law applies to most health insurance plans (excluding dental, vision, short-term coverage, and others listed in the bill) and takes effect November 1, 2025. This ensures children's routine vaccines are fully covered without out-of-pocket costs for families.
HB 1676, the "Kay Floyd SANE Act," creates a new Sexual Assault Nurse Examiner (SANE) Statewide Coordinator position within Oklahoma's District Attorneys Council. The coordinator will oversee forensic medical exam training, recruit SANE professionals, develop local SANE and Sexual Assault Response Team programs, and manage payments from the Sexual Assault Examination Fund. The role requires a minimum annual salary of $125,000, funded through the District Attorneys Council's appropriations. The position is established until October 1, 2025, with the bill taking effect November 1, 2025. This directly affects county-level sexual assault response systems and SANE program expansion statewide.
